Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study

BACKGROUND: Comorbid metabolic disorders in patients with schizophrenia are very common. Patients with schizophrenia who respond to therapy early are often strongly predictive of better treatment outcomes. However, the differences in short-term metabolic markers between early responders and early no...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Junhong, Wu, Jiajia, Liu, Xuebing, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936715/
https://www.ncbi.nlm.nih.gov/pubmed/36800967
http://dx.doi.org/10.1186/s12991-023-00436-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936715/
https://www.ncbi.nlm.nih.gov/pubmed/36800967
http://dx.doi.org/10.1186/s12991-023-00436-3

Ejemplares similares